Effects of Inhaled Corticosteroids on Mortality and Hospitalisation in Elderly Asthma and Chronic Obstructive Pulmonary Disease PatientsAppraising the Evidence

被引:0
|
作者
Jordana K. Schmier
Michael T. Halpern
Mechelle L. Jones
机构
[1] Exponent Inc.,
来源
Drugs & Aging | 2005年 / 22卷
关键词
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Fluticasone Propionate; Salmeterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I
暂无
中图分类号
学科分类号
摘要
Asthma and chronic obstructive pulmonary disease (COPD) are common conditions that have substantial effects on daily functioning and medical resource utilisation. In elderly populations, the use of inhaled corticosteroids (ICS) as a mainstay of treatment in asthma has long been accepted whereas the appropriateness and extent of use of ICS in COPD is not as clear. This paper reviews data associated with ICS treatment in the elderly, specifically characteristics of ICS users, rates of adherence, hospitalisation and mortality associated with ICS treatment.
引用
收藏
页码:717 / 729
页数:12
相关论文
共 50 条
  • [1] Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease
    Sin, DD
    Tu, JV
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (04) : 580 - 584
  • [2] Inhaled corticosteroids in chronic obstructive pulmonary disease: a review
    Telenga, Eef D.
    Kerstjens, Huib A. M.
    Postma, Dirkje S.
    ten Hacken, Nick H.
    van den Berge, Maarten
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (03) : 405 - 421
  • [3] Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease
    Glaab, Thomas
    Taube, Christian
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (01) : 15 - 22
  • [4] Inhaled corticosteroids for chronic obstructive pulmonary disease
    Park, Hye Yun
    Man, S. F. Paul
    Sin, Don D.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [5] Inhaled corticosteroids for chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Novelli, Lucia
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2489 - 2499
  • [6] Inhaled Corticosteroids in Chronic Obstructive Pulmonary DiseaseIs There a Clinical Benefit?
    S. F. Paul Man
    Don D. Sin
    Drugs, 2005, 65 : 579 - 591
  • [7] Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease
    Matera, Maria Gabriella
    Cardaci, Vittorio
    Cazzola, Mario
    Rogliani, Paola
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 533 - 541
  • [8] Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
    Marcel Bonay
    Catherine Bancal
    Bruno Crestani
    Drug Safety, 2002, 25 : 57 - 71
  • [9] Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease
    Malo de Molina, Rosa
    Restrepo, Marcos I.
    Mortensen, Eric M.
    Izquierdo, Jose L.
    Anzueto, Antonio
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (03) : 162 - 166